News | MedEsthetics

At an upcoming MedEsthetics webinar on Feb. 10, experts will discuss how Candela’s Matrix technology helps address GLP-1–related facial volume loss and skin laxity.

How Aesthetic Practices Can Treat GLP-1 Facial Aging: Inside Candela’s Feb. 10 Matrix Webinar

A new expert-led webinar reveals how aesthetic practices can address GLP-1 facial aging effects using Candela’s Matrix technology.

Alexis Lauren launches franchising, inviting entrepreneurs to bring its luxury, membership-driven medspa concept to new markets.

ALEXIS LAUREN Opens Franchise Opportunities for Beauty and Wellness Entrepreneurs with Proven Medspa Model

Florida-based medspa ALEXIS LAUREN is opening its first franchise opportunities, offering entrepreneurs a chance to join a luxury beauty collective backed by a proven membership-driven model.

The Future of Hyaluronic Acid Injectable Fillers with Allergan Aesthetics

The Future of Hyaluronic Acid Injectable Fillers with Allergan Aesthetics

At ASDS, Allergan Aesthetics convened experts to explore the future of hyaluronic acid fillers—dispelling myths, sharing data and emphasizing education for subtle, natural-looking results.

November/December 2025

Read the latest issue

November/December 2025

2025 was a year of growth for VIO Med Spa, and in 2026, it doesn't look like things will be slowing down.

VIO Med Spa Enters 2026 Positioned for Continued Expansion

KilgourMD Partners with N1 Life to Launch Next-Generation Scalp Health Products with Advanced Peptide Delivery Technology

Based on responses from over 3,000 women, O Positiv Health’s 2026 State of the Vagina Report reveals that gaps in education and trust continue to shape women’s health experiences.

Menopause, Menstrual Health and the Care Gap Reshaping Women’s Wellness Services

The Future of Hyaluronic Acid Injectable Fillers with Allergan Aesthetics

The Future of Hyaluronic Acid Injectable Fillers with Allergan Aesthetics

Youth XO +PDRN Serum

Induction Therapies Introduces Youth XO +PDRN Serum

Induction Therapies announces the launch of Youth XO +PDRN Serum, a recovery serum that allows clinicians a new way of integrating PDRN into modern treatment protocols.

The Future of Hyaluronic Acid Injectable Fillers with Allergan Aesthetics

The Future of Hyaluronic Acid Injectable Fillers with Allergan Aesthetics

At ASDS, Allergan Aesthetics convened experts to explore the future of hyaluronic acid fillers—dispelling myths, sharing data and emphasizing education for subtle, natural-looking results.

Mood-enhancing skin care is at the forefront of beauty and wellness, going hand-in-hand with biohacking wellness trends that seek to leverage our physiology for optimal results.

XOMD Announces European Expansion Through XOMD LIFE

XOMD Skincare, the first clinically proven "Moodceutical", designed to elevate both skin quality and emotional well-being, is officially expanding into Europe and beyond through strategic distribution with EvoMD Sp. z o.o.

CosmeticsMD’s rebrand to Cosmetics & Wellness MD reflects its expanded focus on women’s hormone health alongside aesthetic care.

CosmeticsMD Rebrands as Cosmetics & Wellness MD to Expand Women’s Wellness Services

A Massachusetts medical spa is redefining its mission, expanding into women’s hormone health for a more integrated approach to wellness that signals a broader evolution in aesthetic care.

The defining 2026 aesthetics trend is a shift toward inside-out, personalized, regenerative care—where subtle enhancement, whole-body wellness and biocompatible technology work together.

Inside-Out and Innovative: What’s Trending in Aesthetics for 2026

From inside-out radiance to wellness-driven aesthetics, 2026 is shaping up to be the year beauty stops chasing change and starts cultivating longevity.

BodyLogicMD is diversifying its offerings by launching a medical-grade skincare line to complement its hormone therapy and wellness services.

BodyLogicMD Enters Medical-Grade Skincare Market With Four-Product Launch

BodyLogicMD is expanding beyond its core hormone therapy offerings with the launch of a new medical-grade skincare line designed to address common skin concerns.

truFlex evolves beyond aesthetics—now FDA-cleared for rehabilitation and therapeutic muscle care.

Cutera Receives FDA Clearance for Expanded Rehabilitative and Therapeutic Uses of truFlex

FDA clearance expands muscle stimulation technology from aesthetic use to therapeutic and rehabilitative applications, offering new ways to support overall wellness.

Beverly Hills MD Dermal Repair Complex supports skin structure by providing collagen, plant extracts and vitamins associated with skin maintenance.

Beverly Hills MD’s Dermal Repair Complex Wins Skin Anarchy’s 2025 Top Pick Award for Wellness Supplements

Discover the award-recognized formula everyone’s talking about—find out what makes it stand out.

Dr. Pedram Gerami examines the skin of patient and melanoma survivor Heidi Tarr.

Tanning Beds Triple Melanoma Risk, Potentially Causing Broad DNA Damage

Tanning bed use is tied to almost a threefold increase in melanoma risk, and for the first time, scientists have shown how these devices cause melanoma-linked DNA damage across nearly the entire skin surface, reports a new study led by Northwestern Medicine and University of California, San Francisco.

Le-Vel officially launched its XERA Exosome Skin Technology System on Dec. 16, following months of testing and an initial debut in October.

Le-Vel Launches XERA, a Consumer-Ready Skin System Harnessing Exosome Technology

Le-Vel officially released its XERA Exosome Skin Technology System on Dec. 16, following months of development, testing and a highly anticipated debut earlier this fall.

Addyi has received FDA approval for use in postmenopausal women, providing a new, non-hormonal treatment option for Hypoactive Sexual Desire Disorder (HSDD).

Postmenopausal Women Can Now Use Addyi for Low Sexual Desire Following FDA Approval

Postmenopausal women now have an FDA-approved option for low sexual desire that works on brain chemistry, offering new hope for sexual wellbeing.

The FDA is reviewing a proposal to allow bemotrizinol—an internationally used UV filter—to be added as a permitted active ingredient in U.S. sunscreens.

We Might See Bemotrizinol in Sunscreen Soon: FDA Begins Proposal Review

The FDA is weighing whether a popular sunscreen ingredient used abroad could soon become available in U.S. products—potentially changing how we protect the skin.